PCGF6, a component of the Polycomb group (PcG) proteins, plays a pivotal role in the chromatin-modifying complexes involved in transcriptional repression. The chemical class known as PCGF6 Activators encompasses a range of compounds that, while not necessarily targeting PCGF6 directly, can influence the protein's activity or the intricate pathways it is associated with, usually by modulating the chromatin environment.
Among these activators, DNA methyltransferase inhibitors such as 5-Azacytidine and RG108 can modulate the chromatin state, thereby possibly affecting PCGF6 activity. Similarly, histone deacetylase (HDAC) inhibitors like Trichostatin A and Vorinostat work by enhancing histone acetylation. This modification, in turn, has the potential to indirectly influence PCGF6-associated pathways by altering chromatin structure and accessibility. Another influential group within this chemical class targets histone methyltransferases. BIX-01294, for instance, inhibits G9a, while EPZ-6438 focuses on EZH2. By changing histone methylation patterns, these compounds can impact pathways that PCGF6 is intertwined with. BET bromodomain inhibitors like JQ1 and I-BET151 are notable as they modify chromatin accessibility, which can have downstream effects on PCGF6's functionality. Lastly, Anacardic Acid, a histone acetyltransferase inhibitor, can further influence chromatin dynamics, making its mark on the intricate web of pathways that PCGF6 is part of.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor; can modulate chromatin state, potentially influencing PCGF6 activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor; enhances histone acetylation which can indirectly influence PCGF6-associated pathways. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor; can modify chromatin structure, potentially affecting PCGF6. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
Inhibits histone methyltransferase G9a; changes in methylation can impact PCGF6-related pathways. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
DNA methyltransferase inhibitor; may indirectly alter PCGF6 functionality through epigenetic modifications. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
Inhibitor of histone methyltransferase EZH2; might influence pathways associated with PCGF6. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
G9a and GLP histone methyltransferase inhibitor; can modify chromatin state, potentially impacting PCGF6. | ||||||
3-Deazaneplanocin, HCl salt | 120964-45-6 | sc-351856 sc-351856A sc-351856B | 1 mg 5 mg 10 mg | $256.00 $612.00 $936.00 | 2 | |
EZH2 inhibitor; could modify the epigenetic landscape, indirectly influencing PCGF6. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
HDAC inhibitor; its influence on chromatin remodeling can indirectly impact PCGF6. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Histone acetyltransferase inhibitor; can influence chromatin dynamics, potentially affecting PCGF6. | ||||||